We are live on ! Find out more
ISLE

Isleworth Healthcare Acquisition Corporation Common stock

Delisted

ISLE was delisted on the 26th of August, 2022.

69 hedge funds and large institutions have $187M invested in Isleworth Healthcare Acquisition Corporation Common stock in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less capital invested

Capital invested by funds: $187M → $187M (-$275K)

3% less funds holding

Funds holding: 7169 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

47% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 17

Holders
69
Holders Change
-2
Holders Change %
-2.82%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
9
Reduced
17
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
GCL
1
Glazer Capital LLC
New York
$14.7M +$1.24M +125,355 +9%
PC
2
Periscope Capital
Ontario, Canada
$13.5M +$2.9M +294,332 +28%
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$11.6M +$1.67M +169,273 +17%
BL
4
Bleichroeder LP
New York
$9.9M
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$8.41M
MF
6
Magnetar Financial
Illinois
$8.23M -$26.6K -2,700 -0.3%
Goldman Sachs
7
Goldman Sachs
New York
$7.76M +$399K +40,456 +5%
SCM
8
Saba Capital Management
New York
$7.7M +$3.1M +314,491 +68%
FTCM
9
Fir Tree Capital Management
New York
$7.42M
KIM
10
Karpus Investment Management
New York
$7.2M -$93.1K -9,448 -1%
WC
11
Wealthspring Capital
New York
$6.09M -$104K -10,585 -2%
BCM
12
Basso Capital Management
Connecticut
$6.03M +$7.66K +777 +0.1%
RCM
13
Radcliffe Capital Management
Pennsylvania
$5.94M
AC
14
Aristeia Capital
Connecticut
$5.13M
WCMNY
15
Westchester Capital Management (New York)
New York
$4.88M +$2.9M +294,349 +148%
SIA
16
Schechter Investment Advisors
Michigan
$4.49M -$221K -22,381 -5%
WRBC
17
W.R. Berkley Corp
Connecticut
$4.28M +$189K +19,200 +5%
JP Morgan Chase
18
JP Morgan Chase
New York
$4.28M -$2.08M -211,128 -33%
Marshall Wace
19
Marshall Wace
United Kingdom
$4.19M
Hudson Bay Capital Management
20
Hudson Bay Capital Management
Connecticut
$3.8M
AC
21
Athos Capital
Hong Kong
$3.35M
Bank of America
22
Bank of America
North Carolina
$3.21M +$3.2M +324,800 New
WA
23
Whitebox Advisors
Minnesota
$2.73M -$213K -21,600 -7%
SCM
24
Shaolin Capital Management
Florida
$2.44M -$296K -30,000 -11%
DFCM
25
Dark Forest Capital Management
Puerto Rico
$2.14M +$150K +15,264 +8%

ISLE Hedge Fund Activity: Q1 2022 in Review

69 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Isleworth Healthcare Acquisition Corporation Common stock (ISLE) for Q1 2022, worth a combined $187M — down 0.15% from $187M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ISLE and 6 opened new positions — a net loss of 2 holders — while 17 trimmed existing stakes and 9 added.

The largest buyer was Bank of America, opening a new position worth an estimated $3.2M. The largest seller was Kepos Capital, exiting entirely with an estimated $5.17M sold.

  • 69 institutional investors held Isleworth Healthcare Acquisition Corporation Common stock (ISLE) as of Q1 2022, down from 71 in Q4 2021.
  • Funds reported $187M of Isleworth Healthcare Acquisition Corporation Common stock stock for Q1 2022, down 0.15% quarter-over-quarter.
  • 6 funds opened new Isleworth Healthcare Acquisition Corporation Common stock positions in Q1 2022 and 8 closed out, a net change of -2 holders.
  • The largest Isleworth Healthcare Acquisition Corporation Common stock buyer in Q1 2022 was Bank of America, an estimated $3.2M added.
  • The largest Isleworth Healthcare Acquisition Corporation Common stock seller in Q1 2022 was Kepos Capital, an estimated $5.17M sold.

Based on aggregated 13F filings for Q1 2022.